Literature DB >> 19484663

Mechanisms of sublingual immunotherapy.

Guy Scadding1, Stephen Durham.   

Abstract

Allergen-specific sublingual immunotherapy is now recognized to be an efficacious and well-tolerated treatment for allergic rhinitis. Emerging treatment strategies are also aimed at the primary treatment of allergic asthma, particularly allergy to house dust mites. Knowledge of the exact mechanisms of action of sublingual immunotherapy is at a basic level, although there appear to be similarities to the immunological changes seen in subcutaneous immunotherapy. An improved understanding should allow the development of more effective treatment programs and widen the potential use of this form of immunotherapy. This review discusses the possible mechanism of action of sublingual immunotherapy, including data from animal and clinical studies, while comparing this with the current understanding of subcutaneous immunotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19484663     DOI: 10.1080/02770900902785729

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  18 in total

Review 1.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

2.  Sublingual immunotherapy in patients with allergic rhinoconjunctivitis.

Authors:  Deborah Gentile; David P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

Review 3.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

Review 4.  Immunological mechanisms for desensitization and tolerance in food allergy.

Authors:  Rima Rachid; Dale T Umetsu
Journal:  Semin Immunopathol       Date:  2012-07-21       Impact factor: 9.623

5.  Sublingual desensitization for buprenorphine hypersensitivity.

Authors:  Lisa M Stutius; Itai Pessach; Joanne Lee; Mindy S Lo; Sharon Levy; Patricia Schram; Miriam Schizer; Jackson Wong; Wanda Phipatanakul; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2010-03-11       Impact factor: 10.793

Review 6.  Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses.

Authors:  N Novak; E Gros; T Bieber; J-P Allam
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

7.  Sublingual immunotherapy for food allergy and its future directions.

Authors:  Stephen A Schworer; Edwin H Kim
Journal:  Immunotherapy       Date:  2020-07-02       Impact factor: 4.196

Review 8.  Immunotherapy in all aspects.

Authors:  Deniz Hanci; Ethem Şahin; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

Review 9.  Allergen immunotherapy for allergic respiratory diseases.

Authors:  Antonio Cappella; Stephen R Durham
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

10.  Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.

Authors:  Ravi S Swamy; Neha Reshamwala; Tessa Hunter; Soujanya Vissamsetti; Carah B Santos; Fuad M Baroody; Peter H Hwang; Elisabeth G Hoyte; Marco A Garcia; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.